Skip to main content
Log in

Evaluation of Biochemical Markers of Bone Metabolism in Patients with Secondary Hyperparathyroidism

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

We studied the biochemical markers of bone metabolism and bone mineral density (BMD) in 43 male haemodialysis patients. We measured serum levels of carboxyterminal parathyroid hormone (PTH-c), carboxyterminal propeptide of human type I procollagen, calcitonin, intact osteocalcin, cross-linked carboxyterminal telopeptide of human type I collagen, and alkaline phosphatase. We divided all patients into 2 groups (group A and B), those with serum PTH-c levels of 7.5 ng/ml or higher, and those with levels lower than 7.5 ng/ml, respectively. In group A, the levels of markers for bone formation and for bone resorption were notably elevated, while BMD was not significantly decreased. The level of serum markers for bone metabolism appears to be more sensitive than BMD for the clinical assessment of secondary hyperparathyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dumler, F.: Use of bioelectric impedance analysis and dual-energy X-ray absorptiometry for monitoring the nutritional status of dialysis patients. ASAIO J., 43, 256 (1997).

    PubMed  Google Scholar 

  2. Funke, M., Maurer, J., Grabbe, E., Scheler, F.: Comparative studies with quantitative computed tomography and dual-energy X-ray absorptiometry on bone density in renal osteopathy. Rofo. Fortschr. Geb. Röntgenstr. Neuen. Bildgeb. Verfahr., 157, 145 (1992).

    Google Scholar 

  3. Mazzaferro, S., Pasquali, M., Ballanti, P., Bonucci, E., Constantini, S., Chicca, S., De Meo, S., Perruzza, I., Sardella, D., Taggi, F.: Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy. Nephrol. Dial. Transplant., 10, 52 (1995).

    Google Scholar 

  4. Mirzaei, S., Krotla, G., Knoll, P., Koriska, K., Kohn, H.: Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med. Austriaca, 26, 29 (1999).

    PubMed  Google Scholar 

  5. Katagiri, M., Ohtawa, T., Fukunaga, M., Harada, T.: Evaluation of bone loss and serum markers of bone metabolism in patients with hyperparathyroidism. Surg. Today, 25, 598 (1995).

    PubMed  Google Scholar 

  6. Canavese, C., Barolo, S., Gurioli, L., Cadario, A., Portigliatti, M., Isaia, G., Thea, A., Marangella, M., Bongiorno, P., Cavagnino, A., Peona, C., Boero, R., D'Amicone, M., Cardelli, R., Rossi, P., Piccoli, G.: Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis. Int. J. Artif. Organs, 21, 443 (1998).

    PubMed  Google Scholar 

  7. Yamamoto, M., Seedor, J. G., Rodan, G. A., Balena, R.: Endogenous calcitonin attenuates parathyroid hormone-induced cancellous bone loss in the rat. Endocrinology, 136, 788 (1995).

    PubMed  Google Scholar 

  8. Sawamura, T., Sasagawa, I., Kubota, Y., Ishigooka, M., Nakada, T., Adachi, M., Yamaguchi, T.. Serum level of carboxyterminal propeptide of type I procollagen in haemodialysis patients. Int. Urol. Nephrol., 30, 99 (1998).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsui, M., Tanji, N., Teraoka, T. et al. Evaluation of Biochemical Markers of Bone Metabolism in Patients with Secondary Hyperparathyroidism. Int Urol Nephrol 31, 737–741 (1999). https://doi.org/10.1023/A:1007185227485

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007185227485

Keywords

Navigation